Corneal Implants Companies | Forecast by 2033


08 Aug 2024

Share : linkedin twitter facebook

The global corneal implants market was evaluated at USD 426.40 billion in 2023 and is estimated to attain around USD 802.93 billion by 2033, growing at a CAGR of 6.4% during the forecast period. Corneal blindness is one of the major growing issues the world is facing now and governments across the globe are taking significant initiatives which lead to the growth of the corneal implants market.

Corneal Implants Market Statistics

 

The Full Study is Readily Available | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/3333

Market Overview

Corneal implantation is a surgery in which a ring of plastic is placed in the middle layer of the cornea with the help of surgery. A cornea is the clear layer that covers the front part of the eye. This surgery is also performed in case of a patient suffering from nearsightedness, which is also known as myopia. It helps to restore vision, reduce pain, and improve the presence of the injured or diseased cornea. This corneal implantation consists of different procedures such as full-thickness corneal implant that is penetrating keratoplasty (PK), which includes the removal of the entire cornea and replacement it with a donor cornea, partial-thickness corneal transplant (DALK), which is the removal of only the front and middle layers of the cornea, endothelial keratoprosthesis (EK) that includes the replacement of the entire cornea with an artificial cornea and is applicable only in case of severe damage of cornea, and intracorneal ring segments (ICRS) implantation. This procedure is performed under local anesthetic to treat keratoconus.

Corneal disease is considered the fifth reason people become blind. Rising awareness worldwide about the importance of eye donation has led to rapid growth in the corneal implants market. Some of the significant market players who have made major contributions to this market are Florida Lions Eye Bank, DIOPTEX, CorneaGen, KeraMed Inc., and many others.

  • Progressive bio-engineered corneal implants: The expansion of bio-engineered corneal implants made from artificial or bio-active resources is evolving. These implants intend to create the same type of natural corneal tissue or as close as possible and deliver better incorporation with the real tissue. The study is engrossed in enhancing the bio-compatibility and efficient results of such implants.
  • Modified corneal implants: By advancing the imaging and 3D printing expertise, modified corneal implants are gradually becoming possible. Corneal implants are modified to match the exceptional anatomy, enhancing the results and visual insight.
  • Improved surgical techniques: Revolutions in surgical techniques, such as evolved microkeratomes and femtoseconds, are increasing the accuracy and results of corneal implantation surgery. Such revolutionization intends to reduce complications and increase the recovery time for patients.

Rising cases of corneal disease are driving the corneal implants market

The rapidly rising cases of corneal disease have raised concern among pharmaceutical companies, governmental organizations, and others, ultimately driving the corneal implants market. Many companies collaborate to fund research studies to develop corneal implantation surgeries to enhance the success rate. In the current world, corneal blindness is a significant contributor to the problem and has a larger occurrence in low-earning countries of the emerging world where capital and organization are inadequate.

According to the World Health Organization (WHO), nearly 2 billion people worldwide live with vision blindness or impairment, of which approximately 1.1 billion people are living with vision loss due to short or far-sightedness, glaucoma, and many others. It is expected from the survey that this issue of eyesight will be a major concern for almost half of the population living in low to middle-income countries by 2050.

Due to an extended procedure of testing and then treatment, it needs too much time and expense, which is hindering the growth of the corneal implants market. Corneal implantation requires various tests and equipment, which have high costs, hence the surgery. Also, it is a long procedure that includes several steps that take time to treat a patient. There is a need for more advancement to reduce the treatment time and also measures that can help people financially.

Top Companies in The Corneal Implants Market

  • Beauty of Sight
  • Presbia PLC
  • Alcon Inc.
  • KeraMed Inc.
  • Aurolab
  • Pantheon Vision
  • San Diego Eye Bank
  • Entod Pharmaceuticals
  • CorneaGen
  • DIOPTEX
  • Massachusetts Eye and Ear
  • AJL Ophthalmic S.A.

A Recent Development by Pantheon Vision

  • In November 2023, Pantheon Vision, which is an early-stage biotech company developing bioengineered corneal implants, launched $2.5m in seed funding to grow bioengineered corneal implants to treat corneal blindness and is anticipated to decrease dependence on donated corneal implants.

A Recent Development by Entod Pharmaceuticals

  • In September 2023, Entod Pharmaceuticals, which is an international research-based pharmaceutical company, launched a campaign to promote eye donation during National Eye Donation Fortnight.

Regional Insights

North American region dominated the corneal implants market in 2023 due to the growing number of cases of corneal disease. Governments in countries such as America, Canada, and others actively take the initiative to spread awareness about these diseases. For instance, the Food Drugs Administration (FDA) first time approved Durysta, which is a dissolvable ocular implant that has been studied and developed to relieve patients suffering from eye pressure due to open-angle glaucoma or high eye pressure, which is commonly known as ocular hypertension.

Studies have found that in Canada, approximately 5000 cornea implantations are performed every year under experts. According to the Eye Bank Association of America, in 2023, approximately 137,697 entire tissue retrievals from 69,637 donors. Nearly around 63.4% of corneal donors were registered in a donor records office. In 2023, donors were found to be up to 12.8%, approximately, and overall corneas donated were calculated up to 12.4% compared to 2022.

Due to advancements in medical facilities in Europe, the corneal implant market is witnessing rapid growth. The growing investment in the healthcare sector helps the market grow by compelling competitors to enhance research studies to revolutionize the treatment procedure. Such continuous effort informs people of the success rate in this field, which makes it reliable and raises concerns at the same time.

Market Potential and Growth Opportunity

Advancement in treatment methods expanding the corneal implants market scope

Advancements in treatment procedures are anticipated to boost the development and expansion of the corneal implant market. Eventually, marking to advance patient results and enlarge the application of this innovative medical intrusion, these progressions include a variety of corneal implant investigation fields, such as arrangement, manufacturing methods, and planning. For instance, in 2022, medical experts and polymer researchers from the University of Melbourne collaborated to generate a novel, patentable technique that might advance consequences for patients undergoing corneal implantation surgery. Thus, technical progressions in corneal implants are anticipated to deliver development chances for the marketplace during the predicted period.

Corneal Implants Market Highlights

Report Attribute Key Statistics
Market Revenue in 2024 USD 454.54 Billion
Market Revenue by 2033 USD 802.93 Billion
CAGR 6.4%
Quantitative Units Revenue in USD million/billion, Volume in units
Largest Market North America
Base Year 2023
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Corneal Implants Market News

  • In April 2023, at the University of Granada, the first clinical trial for human artificial cornea was completed. This is designed and generated from biomaterials and stem cells by researchers.
  • In July 2022, Carl Zeiss Meditech, which is a multinational medical technology company, and Precise Bio, which is a 3D printing and tissue engineering company that creates scalable and repeatable bio-fabricated organs from patient cells. Together, these companies announced that they had signed a joint venture to develop and commercialize fabricated corneal tissues for implantation in patients who need endothelial keratoplasty and natural lenticular transplant.

Market Segmentation

By Type

  • Human Cornea
  • Synthetic

By Surgery Method

  • Penetrating Keratoplasty
  • Endothelial Keratoplasty

By Application

  • Keratoconus
  • Fuchs Dystrophy
  • Infectious Keratitis
  • Corneal Ulcers

Buy this Research Report@ https://www.precedenceresearch.com/corneal-implants-market

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308

Related Reports